Until January 2024, Dr. Kenney will remain a postdoctoral researcher and a Merck Fellow of the Damon Runyon Cancer Research Foundation, working in the laboratory of Prof. Emily Balskus at Harvard University. Dr. Kenney earned an S.B. in Chemistry from the Massachusetts Institute of Technology, after studying the chemotherapeutic natural product bleomycin in the laboratory of Prof. JoAnne Stubbe. As a graduate student, Dr. Kenney joined the laboratory of Prof. Amy Rosenzweig at Northwestern University, investigating the production and biological roles of copper-binding natural products, ultimately receiving a Ph.D. in Biological Sciences. Support for this research came from several sources, including an American Heart Association Predoctoral Fellowship and a Northwestern University Presidential Fellowship. Dr. Kenney’s postdoctoral work in the Balskus group has focused on new enzyme families that form nitrogen-nitrogen bonds in diverse natural products.